Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Institutional Investor Advisor Individual Investor


Why the Health Care Rebound Has Staying Power

October 29, 2018

Senior Health Care Analysts Marshall Gordon and Nicholas Wu join Jeffrey Schulze to analyze drug pricing narratives and the health care M&A landscape, discuss opportunities created by innovation among biotechnology and pharmaceutical companies and highlight health care opportunities abroad.

Marshall Gordon

Senior Analyst - Health Care
21 Years experience
13 Years at ClearBridge

Jeffrey Schulze, CFA

Investment Strategist
16 Years experience
7 Years at ClearBridge

Nicholas Wu, PhD

Senior Analyst - Health Care
19 Years experience
14 Years at ClearBridge

Related Perspectives

  • Past performance is no guarantee of future results. The opinions and views expressed herein are of the commentator as of the date shown, and may differ from other managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results, or investment advice. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments nor its information providers are responsible for any damages or losses arising from any use of this information.